Showing results (571-580 of 668) with videos related to
Sort By:
Pageof 67
JAMA Oncology|November 22, 2019
Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical TrialDouglas W Arthur, Kathryn A Winter, Henry M Kuerer, et al.JAMA Oncology|April 22, 2021
Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases: Findings From the NRG-BR001 Phase 1 TrialSteve Chmura, Kathryn A Winter, Clifford Robinson, et al.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 8, 2009
Wireless Instantaneous Neurotransmitter Concentration Sensing System (WINCS) for intraoperative neurochemical monitoringChristopher J Kimble, David M Johnson, Bruce A Winter, et al.International Journal of Radiation Oncology, Biology, Physics|August 20, 2023
Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848Leila T Tchelebi, Kathryn A Winter, Ross A Abrams, et al.International Journal of Radiation Oncology, Biology, Physics|July 20, 2017
NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast RecurrenceDouglas W Arthur, Kathryn A Winter, Henry M Kuerer, et al.European Journal of Pediatrics|August 20, 2020
Infliximab in young paediatric IBD patients: it is all about the dosingMaria M E Jongsma, Dwight A Winter, Hien Q Huynh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2021
Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804Beryl McCormick, Kathryn A Winter, Wendy Woodward, et al.Journal of Medicinal Chemistry|January 17, 1997
Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifeneT A Grese, S Cho, D R Finley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2023
Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical TrialJeff M Michalski, Kathryn A Winter, Bradley R Prestidge, et al.Cancer|March 11, 2026
Patient-reported outcomes in NRG Oncology RTOG 1010: Phase 3 trial evaluating the addition of trastuzumab to trimodality treatment of HER2 overexpressing esophageal adenocarcinomaLisa A Kachnic, Jennifer Moughan, Theodore S Hong, et al.Pageof 67